Asplenia – Diagnostics – Overview of Information and Clinical Research

Diagnosing asplenia—the absence or dysfunction of the spleen—is critical for preventing life-threatening infections. While some people know they’ve had their spleen removed, others may not realize their spleen isn’t working properly due to underlying conditions. Early detection through blood tests and careful medical evaluation can make the difference between living safely without a spleen and facing severe, sometimes fatal complications.

Introduction: Who Should Seek Diagnostic Evaluation

Not everyone who lacks a functioning spleen is aware of their condition. People who have undergone surgical removal of the spleen due to trauma, such as a car accident or sports injury, typically know about their anatomic asplenia—meaning they physically do not have a spleen. However, many individuals have what doctors call functional asplenia, where the spleen is present in the body but does not work correctly.^[1]

Diagnostic evaluation is particularly important for people with certain medical conditions that can damage the spleen over time. Those with sickle cell disease, celiac disease, lupus, advanced HIV infection, or liver disease should discuss splenic function testing with their healthcare provider, as these conditions can silently impair the spleen’s ability to protect against infections.^[2] Similarly, people with complex congenital heart disease need evaluation, as this represents one of the most important clinical indications for assessing whether the spleen is functioning properly.^[4]

The stakes are high because without a working spleen, the body struggles to fight certain bacteria that have protective outer coverings, called encapsulated bacteria. These include Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis—organisms that can cause pneumonia, meningitis, and blood poisoning. The risk of developing a life-threatening bacterial infection is higher in children with asplenia than in adults, though anyone without splenic function remains at increased risk throughout their lifetime.^[2]

⚠️ Important

Some older patients who had their spleen removed years ago may not remember or may not have been fully informed about the implications of living without a spleen. If you’ve had abdominal surgery in the past or have a medical condition affecting your blood or immune system, it’s worth asking your doctor whether your spleen might be affected. Early identification allows for proper preventive care.

If you have unexplained fevers, chills, rapid heart rate, fatigue, confusion, or irritability, especially if you know you don’t have a spleen or have a condition that affects splenic function, you should seek medical attention immediately. These symptoms could signal a serious infection that requires urgent treatment.^[2]

Classic Diagnostic Methods for Identifying Asplenia

The most challenging aspect of managing asplenia is establishing the diagnosis in the first place. While identifying anatomic asplenia in patients who have undergone splenectomy is straightforward, diagnosing functional asplenia or congenital absence of the spleen can be much more difficult. In fact, some cases are only discovered at autopsy, highlighting the critical importance of proper diagnostic evaluation.^[4]

Medical History and Physical Examination

Your healthcare provider will begin by asking detailed questions about your medical history and any symptoms you’re experiencing. They will want to know if you have a biological family history of asplenia, particularly congenital asplenia, which can be associated with genetic changes in the RPSA gene or occur as part of rare syndromes like heterotaxy.^[2] The provider will also inquire about any previous surgeries, especially those involving the abdomen, and whether you have conditions like sickle cell disease or celiac disease that could affect splenic function.

During the physical examination, the doctor will check for signs of an enlarged spleen by feeling your abdomen. Normally, the spleen is not palpable—meaning you cannot feel it by pressing on the abdomen—and it measures on average about 10.65 by 5.16 centimeters. Normal spleen size can vary by sex and race; for example, men typically have larger spleens than women, and white individuals tend to have larger spleens compared to African American individuals.^[1] However, the physical exam might not reveal obvious signs of asplenia itself, making laboratory tests essential for diagnosis.^[2]

Peripheral Blood Smear Analysis

Often, the first and most important clues to functional asplenia in an otherwise asymptomatic patient come from abnormalities found in the peripheral blood smear. This is a laboratory test where a drop of blood is spread thinly on a glass slide, stained, and examined under a microscope. The initial evaluation should begin with a careful review to identify what are called Howell-Jolly bodies.^[4]

Howell-Jolly bodies are small, round fragments of nuclear material that remain inside red blood cells. In a person with a functioning spleen, these particles are normally removed by the spleen as it filters the blood. However, when the spleen is absent or not working properly, these bodies persist in the circulating red blood cells and become visible under the microscope. The presence of Howell-Jolly bodies in the peripheral blood smear of an individual older than seven days of age strongly suggests splenic dysfunction.^[4] It’s worth noting that if Howell-Jolly bodies are absent in a patient who has had their spleen removed, this may indicate the presence of an accessory spleen—a small, extra spleen that can sometimes take over some filtering functions.^[6]

Beyond Howell-Jolly bodies, the blood smear may show other characteristic changes in asplenic patients. These include target cells (red blood cells that look like a bullseye under the microscope), increased numbers of white blood cells called lymphocytes (lymphocytosis), increased numbers of another type of white blood cell called neutrophils (neutrophilia), and an elevated platelet count (thrombocytosis), which typically occurs in the first weeks to months after splenectomy.^[6]

Additional Laboratory Tests

Beyond the blood smear, other laboratory tests can provide supporting evidence of asplenia or hyposplenism. Blood tests may show decreased production of certain antibodies called immunoglobulins, specifically IgG and IgM. These antibodies are crucial for fighting infections because they help tag bacteria for destruction through a process called opsonization and activate the complement system, which is part of the body’s immune defense. When these antibody levels are low, it leads to decreased complement activation and less effective clearance of bacteria from the bloodstream.^[6]

Imaging Studies

While imaging is not always necessary for diagnosing asplenia, it can be helpful in certain situations. Ultrasound, computed tomography (CT) scans, or magnetic resonance imaging (MRI) can be used to visualize the spleen and determine whether it is present, absent, or abnormally small. These imaging tests are particularly useful when trying to distinguish between anatomic and functional asplenia, or when looking for accessory spleens in patients who have had a splenectomy but continue to show some signs of splenic function.

Radionuclide scanning using specialized tracers can also help assess splenic function by showing how well the spleen is filtering blood. However, these more advanced imaging tests are typically reserved for cases where the diagnosis remains unclear after initial blood tests and physical examination.

Diagnostics for Clinical Trial Qualification

Clinical trials investigating new treatments or preventive strategies for patients with asplenia require specific diagnostic criteria to ensure participants truly have compromised splenic function. The standard tests used to qualify patients for such trials mirror the classic diagnostic methods but are applied with greater rigor and documentation.

For enrollment in most clinical trials involving asplenic patients, a confirmed diagnosis through peripheral blood smear showing Howell-Jolly bodies is typically required. Trials may specify that the blood smear must demonstrate a certain number or percentage of red blood cells containing these nuclear remnants. Some studies may also require documentation of the underlying cause of asplenia, whether it be surgical removal (with operative reports), congenital absence (with imaging confirmation), or functional hyposplenism due to a documented medical condition.^[4]

Clinical trials testing vaccines or antibiotic prophylaxis strategies often require baseline immunological testing before enrollment. This can include measuring levels of specific antibodies against encapsulated bacteria such as pneumococcal antibodies, meningococcal antibodies, and antibodies against Haemophilus influenzae type b. These baseline measurements allow researchers to determine how well a patient’s immune system can respond to vaccination or other interventions being tested in the trial.^[6]

Participants may also undergo more detailed blood cell counts and flow cytometry to assess the numbers and types of immune cells present in their bloodstream. Flow cytometry is a sophisticated laboratory technique that can identify and count different populations of white blood cells, including B cells and T cells, which play important roles in fighting infections. Studies have shown that people with asplenia or hyposplenism often lack specific types of immune cells called IgM memory B cells, which are crucial for responding to polysaccharide vaccines—the type of vaccines used to protect against encapsulated bacteria.^[3]

⚠️ Important

If you’re considering participating in a clinical trial for asplenia-related research, you may need to provide complete medical records documenting your diagnosis and treatment history. This includes vaccination records, any history of infections or hospitalizations, and details about preventive antibiotics you may be taking. Keeping thorough personal health records can expedite the screening process for trial participation.

For trials specifically examining infection prevention strategies, researchers may require evidence that participants are at particularly high risk. This could include documentation of previous episodes of severe infection, the presence of other immune system problems, or very low levels of protective antibodies despite previous vaccination attempts. Children are often studied separately from adults because they face different levels of risk, with younger children generally being at higher risk for severe infections due to their developing immune systems.^[2]

Some clinical trials may also use specialized imaging or nuclear medicine scans to quantify the degree of splenic dysfunction in participants with functional asplenia. These studies can measure how effectively any remaining splenic tissue is filtering blood and performing its immune functions. Such detailed functional assessments help researchers categorize patients by severity of splenic dysfunction, which can be important for determining who might benefit most from experimental interventions.

Genetic testing may be required for trials focusing on congenital asplenia, particularly those investigating the RPSA gene mutations or conditions like heterotaxy syndrome. These genetic studies help researchers understand the underlying causes of congenital asplenia and may guide the development of future therapies.^[2] Family history documentation is also important in these trials, as some forms of congenital asplenia can run in families.

Prognosis and Survival Rate

Prognosis

The prognosis for individuals living with asplenia varies significantly depending on several factors, including age at diagnosis, the underlying cause of splenic dysfunction, overall immune status, and adherence to preventive measures. Adults who lose their spleen tend to cope better than children born without one, though both groups require ongoing medical attention and careful monitoring.^[5]

The most critical factor affecting prognosis is whether appropriate preventive measures are implemented and maintained. With proper management, including vaccination, antibiotic prophylaxis when indicated, and patient education about recognizing early signs of infection, individuals with asplenia can lead normal, healthy lives with a regular lifespan. The risk of serious infection, though present, is manageable with appropriate precautions.^[2]

However, without adequate preventive care, the prognosis can be significantly worse. The majority of serious infections—approximately fifty to seventy percent—occur within the first two years following splenectomy. Despite this early clustering of infections, patients have experienced serious complications more than forty years after losing their spleen, indicating that the increased risk is truly lifelong.^[12]

Patients with conditions associated with defective cellular immunity face a more guarded prognosis. Those with Hodgkin’s disease, hypogammaglobulinemia, or those undergoing chemotherapy or radiation therapy have impaired ability to mount an effective antibody response to infections and vaccinations. Similarly, patients who have had bone marrow transplantation face additional immune challenges beyond the absence of splenic function.^[12]

Children face particular challenges, as they often have lower levels of specific antibodies against encapsulated organisms compared to adults. The heightened risk of infections can be somewhat reduced by ensuring that children without a functioning spleen receive all recommended vaccines and, in many cases, remain on preventive antibiotics throughout childhood.^[5] Most guidelines recommend continuing antibiotic prophylaxis for asplenic children until at least five years of age, though some children and adults may need to take antibiotics for longer periods or even indefinitely.^[6]

Survival Rate

The survival statistics for asplenic patients are primarily determined by their risk of developing overwhelming post-splenectomy infection, often abbreviated as OPSI. This is a syndrome of fulminant sepsis that occurs in patients without functioning spleens and is associated with extremely high mortality rates if not treated promptly and aggressively.^[18]

Without treatment, overwhelming post-splenectomy infection carries a mortality rate of approximately seventy percent. This devastating statistic underscores the critical importance of early recognition and immediate intervention. However, when patients are educated to seek medical attention at the first sign of illness and receive prompt, aggressive treatment, mortality can be reduced to approximately ten to forty percent.^[6] More than half of patients who die from these infections do so within forty-eight hours of admission to the hospital, highlighting how rapidly these infections can progress.^[12]

The overall risk of developing an infection severe enough to require hospitalization is substantial. In one large study, the cumulative risk of serious infection was thirty-three percent at the end of a ten-year follow-up period. However, the risk of fulminant infection specifically is lower, estimated at approximately one case per five hundred person-years of observation.^[12]

The risk of overwhelming infection has been quantified as elevated by as much as three hundred fifty-fold compared to individuals with functioning spleens, though this dramatic increase applies primarily to infections with specific encapsulated bacteria rather than all types of infections.^[3] The reported mortality from overwhelming post-splenectomy infection has ranged from fifty to eighty percent in various studies, despite the availability of appropriate antibiotic therapy and intensive care interventions.^[12]

It’s important to emphasize that these statistics reflect outcomes across all asplenic patients, including those who may not have received optimal preventive care. Patients who maintain up-to-date vaccinations, take prescribed prophylactic antibiotics when recommended, carry emergency antibiotics for immediate use at the first sign of infection, and seek prompt medical care have significantly better outcomes. With the increasing prevalence of antibiotic-resistant bacteria, particularly antibiotic-resistant pneumococci, the appropriate use of pneumococcal vaccines has become especially important for improving survival outcomes.^[12]

#1 Clinical Trials Search in Europe

Asplenia – Diagnostics

Introduction: Who Should Seek Diagnostic Evaluation